Home » Topics » Regulatory

Regulatory
RSS

FDA approval obtained for Prandin

Dec. 29, 1997

TOBI approved by FDA for management of CF patients

Dec. 29, 1997

FDA clears new oral treatment for hair loss in men

Dec. 29, 1997

Chiron's Proleukin recommended for approval for new indication

Dec. 23, 1997

FDA clears Trovan, Pfizer's broad-spectrum quinolone

Dec. 22, 1997

Nutropin AQ also wins FDA approval

Dec. 19, 1997

Antizol cleared by FDA as first antidote for ethylene glycol poisoning

Dec. 19, 1997

Antiacne activity of oral contraceptives

Dec. 19, 1997

First biologic approved for treatment of diabetic foot ulcers

Dec. 18, 1997

Daiichi's Floxin receives FDA approval

Dec. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...